nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—psoriasis	0.717	1	CbGaD
Niclosamide—CYP1A2—Clobetasol propionate—psoriasis	0.0726	0.459	CbGbCtD
Niclosamide—CYP1A2—Methoxsalen—psoriasis	0.0381	0.241	CbGbCtD
Niclosamide—CYP2C9—Cholecalciferol—psoriasis	0.0228	0.144	CbGbCtD
Niclosamide—CYP2C9—Cyclosporine—psoriasis	0.015	0.0945	CbGbCtD
Niclosamide—CYP2C9—Dexamethasone—psoriasis	0.00985	0.0622	CbGbCtD
Niclosamide—STAT3—skin epidermis—psoriasis	0.00954	0.44	CbGeAlD
Niclosamide—STAT3—endothelium—psoriasis	0.00692	0.319	CbGeAlD
Niclosamide—STAT3—skin of body—psoriasis	0.00295	0.136	CbGeAlD
Niclosamide—STAT3—tendon—psoriasis	0.00225	0.104	CbGeAlD
Niclosamide—STAT3—IL2-mediated signaling events—SOCS1—psoriasis	0.000693	0.00674	CbGpPWpGaD
Niclosamide—STAT3—Interferon type I signaling pathways—SOCS1—psoriasis	0.000693	0.00674	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—SOCS1—psoriasis	0.000693	0.00674	CbGpPWpGaD
Niclosamide—STAT3—Interleukin-6 signaling—IL6—psoriasis	0.000682	0.00663	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—IFNG—psoriasis	0.000656	0.00638	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—SOCS1—psoriasis	0.000646	0.00628	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—NFKBIA—psoriasis	0.000645	0.00627	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—NOS2—psoriasis	0.000645	0.00627	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—SOCS1—psoriasis	0.000637	0.0062	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—CRP—psoriasis	0.000627	0.0061	CbGpPWpGaD
Niclosamide—STAT3—PDGF Pathway—NFKBIA—psoriasis	0.000619	0.00601	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—IL4—psoriasis	0.000605	0.00588	CbGpPWpGaD
Niclosamide—STAT3—Physiological and Pathological Hypertrophy  of the Heart—JUN—psoriasis	0.000585	0.00569	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—IFNG—psoriasis	0.000585	0.00569	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—CRP—psoriasis	0.000584	0.00568	CbGpPWpGaD
Niclosamide—STAT3—Interleukin-11 Signaling Pathway—ICAM1—psoriasis	0.000566	0.0055	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—CD4—psoriasis	0.000565	0.00549	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—CD8A—psoriasis	0.000565	0.00549	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IL4—psoriasis	0.000556	0.00541	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—NFKBIA—psoriasis	0.000533	0.00518	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—TYK2—psoriasis	0.000528	0.00514	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—LEP—psoriasis	0.000527	0.00513	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—JUN—psoriasis	0.000506	0.00492	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—HLA-A—psoriasis	0.000504	0.0049	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IFNG—psoriasis	0.000495	0.00481	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—CD4—psoriasis	0.000478	0.00465	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—NFKBIA—psoriasis	0.000477	0.00464	CbGpPWpGaD
Niclosamide—STAT3—IL17 signaling pathway—NFKB1—psoriasis	0.000474	0.00461	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—TYK2—psoriasis	0.000469	0.00456	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—HLA-DRB1—psoriasis	0.00046	0.00447	CbGpPWpGaD
Niclosamide—STAT3—Interleukin-11 Signaling Pathway—TYK2—psoriasis	0.00046	0.00447	CbGpPWpGaD
Niclosamide—STAT3—Signaling of Hepatocyte Growth Factor Receptor—JUN—psoriasis	0.000458	0.00445	CbGpPWpGaD
Niclosamide—STAT3—IFN-gamma pathway—IFNG—psoriasis	0.000439	0.00427	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—NOS2—psoriasis	0.000438	0.00426	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—TYK2—psoriasis	0.000436	0.00424	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—TNF—psoriasis	0.000425	0.00413	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—NFKB1—psoriasis	0.000412	0.004	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—NFKBIA—psoriasis	0.000411	0.004	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—DDX58—psoriasis	0.000411	0.004	CbGpPWpGaD
Niclosamide—STAT3—PDGF Pathway—JUN—psoriasis	0.00041	0.00399	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000409	0.00398	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—NFKBIA—psoriasis	0.000406	0.00395	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—NOS2—psoriasis	0.000406	0.00395	CbGpPWpGaD
Niclosamide—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000404	0.00393	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—TYK2—psoriasis	0.000403	0.00391	CbGpPWpGaD
Niclosamide—STAT3—IL-5 Signaling Pathway—JUN—psoriasis	0.000402	0.00391	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—NFKBIA—psoriasis	0.000401	0.0039	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—NOS2—psoriasis	0.000401	0.0039	CbGpPWpGaD
Niclosamide—STAT3—Notch-mediated HES/HEY network—CD4—psoriasis	0.000395	0.00384	CbGpPWpGaD
Niclosamide—STAT3—ErbB2/ErbB3 signaling events—JUN—psoriasis	0.000394	0.00383	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—LEP—psoriasis	0.000393	0.00382	CbGpPWpGaD
Niclosamide—STAT3—Interferon type I signaling pathways—TYK2—psoriasis	0.000391	0.0038	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—TYK2—psoriasis	0.000391	0.0038	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—NFKBIA—psoriasis	0.000387	0.00377	CbGpPWpGaD
Niclosamide—STAT3—IL-2 Signaling Pathway—JUN—psoriasis	0.000387	0.00376	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—CXCL8—psoriasis	0.00038	0.00369	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—CXCL8—psoriasis	0.000368	0.00357	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—IFNG—psoriasis	0.000366	0.00355	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—IFNG—psoriasis	0.000366	0.00355	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—PPARG—psoriasis	0.000362	0.00352	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—TYK2—psoriasis	0.000359	0.00349	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—JUN—psoriasis	0.000353	0.00343	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—HLA-DRB1—psoriasis	0.000352	0.00342	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by TCPTP—VEGFA—psoriasis	0.000351	0.00341	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00035	0.0034	CbGpPWpGaD
Niclosamide—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000345	0.00336	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—SOCS1—psoriasis	0.000343	0.00334	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Leptin—IL6—psoriasis	0.000343	0.00333	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—IL6—psoriasis	0.000343	0.00333	CbGpPWpGaD
Niclosamide—STAT3—IL-3 Signaling Pathway—JUN—psoriasis	0.000342	0.00332	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—NFKB1—psoriasis	0.00034	0.00331	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—TYK2—psoriasis	0.000337	0.00327	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IFNG—psoriasis	0.000336	0.00327	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000332	0.00323	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—CD4—psoriasis	0.000325	0.00316	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—SOCS1—psoriasis	0.000322	0.00313	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—TNF—psoriasis	0.00032	0.00311	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—JUN—psoriasis	0.000316	0.00307	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—JUN—psoriasis	0.000316	0.00307	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—JUN—psoriasis	0.000316	0.00307	CbGpPWpGaD
Niclosamide—STAT3—RAC1 signaling pathway—JUN—psoriasis	0.000316	0.00307	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—NFKB1—psoriasis	0.000304	0.00296	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—NFKB1—psoriasis	0.000304	0.00296	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KIR2DS1—psoriasis	0.000298	0.0029	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000284	0.00276	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—NFKB1—psoriasis	0.00028	0.00272	CbGpPWpGaD
Niclosamide—STAT3—Notch Signaling Pathway—NFKB1—psoriasis	0.000276	0.00268	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—JUN—psoriasis	0.000269	0.00262	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—JUN—psoriasis	0.000269	0.00262	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-C—psoriasis	0.000268	0.00261	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—NFKB1—psoriasis	0.000262	0.00255	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—NFKB1—psoriasis	0.000259	0.00252	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IL6—psoriasis	0.000258	0.00251	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—psoriasis	0.000256	0.00249	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—LEP—psoriasis	0.000253	0.00246	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—CD4—psoriasis	0.000248	0.00241	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—NFKB1—psoriasis	0.000247	0.0024	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.000238	0.00231	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TNF—psoriasis	0.000237	0.0023	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—PCNA—psoriasis	0.000236	0.00229	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—NFKB1—psoriasis	0.000234	0.00227	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—IL6—psoriasis	0.000229	0.00223	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—TYK2—psoriasis	0.000224	0.00218	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-E—psoriasis	0.000223	0.00216	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—PPARG—psoriasis	0.000221	0.00215	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NFKBIA—psoriasis	0.000218	0.00211	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—psoriasis	0.000214	0.00208	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—IL6—psoriasis	0.000213	0.00207	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—IL6—psoriasis	0.000213	0.00207	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—JUN—psoriasis	0.000212	0.00206	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—psoriasis	0.0002	0.00194	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—TNF—psoriasis	0.000192	0.00187	CbGpPWpGaD
Niclosamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000188	0.00183	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—SOCS1—psoriasis	0.000186	0.00181	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—JUN—psoriasis	0.000186	0.00181	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—JUN—psoriasis	0.000186	0.00181	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CAT—psoriasis	0.000185	0.0018	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CARM1—psoriasis	0.000182	0.00177	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—TYK2—psoriasis	0.000181	0.00176	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—TP53—psoriasis	0.00018	0.00175	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—psoriasis	0.000179	0.00174	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000176	0.00171	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—TP53—psoriasis	0.000176	0.00171	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—NFKB1—psoriasis	0.000175	0.0017	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000174	0.00169	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000171	0.00167	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000168	0.00163	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriasis	0.000166	0.00162	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—TYK2—psoriasis	0.000163	0.00158	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—JUN—psoriasis	0.000162	0.00157	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000161	0.00156	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-B—psoriasis	0.000159	0.00154	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERAP1—psoriasis	0.000152	0.00148	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—TYK2—psoriasis	0.000151	0.00147	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000151	0.00146	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000149	0.00144	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000148	0.00144	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—TYK2—psoriasis	0.000148	0.00144	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-A—psoriasis	0.000147	0.00143	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000146	0.00142	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—JUN—psoriasis	0.000144	0.0014	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—NFKB1—psoriasis	0.000139	0.00135	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HCAR2—psoriasis	0.000137	0.00133	CbGpPWpGaD
Niclosamide—STAT3—Immune System—DDX58—psoriasis	0.000134	0.0013	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	0.000134	0.0013	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	0.000134	0.0013	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—JUN—psoriasis	0.000131	0.00128	CbGpPWpGaD
Niclosamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000131	0.00127	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.00013	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—ICAM1—psoriasis	0.000129	0.00125	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CXCL8—psoriasis	0.000126	0.00123	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NFKBIA—psoriasis	0.000126	0.00122	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TAGAP—psoriasis	0.000119	0.00116	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—JUN—psoriasis	0.000118	0.00114	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TNF—psoriasis	0.000117	0.00114	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—NFKB1—psoriasis	0.000113	0.0011	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL6—psoriasis	0.000112	0.00109	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000112	0.00109	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL6—psoriasis	0.00011	0.00107	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—TYK2—psoriasis	0.000105	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—TYK2—psoriasis	0.000103	0.001	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ITGAL—psoriasis	0.000102	0.000989	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IFNG—psoriasis	9.8e-05	0.000953	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CXCL8—psoriasis	9.55e-05	0.000929	CbGpPWpGaD
Niclosamide—STAT3—Immune System—REL—psoriasis	9.52e-05	0.000925	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—psoriasis	9.46e-05	0.000919	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFIH1—psoriasis	9.24e-05	0.000898	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—JUN—psoriasis	8.88e-05	0.000863	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—psoriasis	8.86e-05	0.000862	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-C—psoriasis	8.76e-05	0.000851	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—LEP—psoriasis	8.71e-05	0.000847	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	8.69e-05	0.000845	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TNFAIP3—psoriasis	8.65e-05	0.000841	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—NFKB1—psoriasis	8.55e-05	0.000831	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—NFKB1—psoriasis	8.16e-05	0.000793	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NFKB1—psoriasis	8.02e-05	0.00078	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—psoriasis	7.97e-05	0.000775	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—VEGFA—psoriasis	7.76e-05	0.000754	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—psoriasis	7.76e-05	0.000754	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PPARG—psoriasis	7.59e-05	0.000737	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—psoriasis	7.39e-05	0.000718	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-E—psoriasis	7.27e-05	0.000707	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—psoriasis	7.23e-05	0.000702	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.22e-05	0.000702	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL20—psoriasis	7.13e-05	0.000693	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—psoriasis	7.1e-05	0.00069	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TYK2—psoriasis	6.65e-05	0.000646	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	6.54e-05	0.000636	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.24e-05	0.000607	CbGpPWpGaD
Niclosamide—STAT3—Immune System—SOCS1—psoriasis	6.07e-05	0.00059	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.01e-05	0.000584	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—psoriasis	5.86e-05	0.00057	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.45e-05	0.00053	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—psoriasis	5.38e-05	0.000523	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—psoriasis	5.37e-05	0.000522	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NFKB1—psoriasis	5.18e-05	0.000503	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-B—psoriasis	5.18e-05	0.000503	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—psoriasis	5.12e-05	0.000498	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—psoriasis	5.03e-05	0.000489	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-A—psoriasis	4.8e-05	0.000466	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—psoriasis	4.7e-05	0.000457	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.67e-05	0.000454	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.67e-05	0.000454	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CRP—psoriasis	4.58e-05	0.000445	CbGpPWpGaD
Niclosamide—STAT3—Disease—HLA-A—psoriasis	4.43e-05	0.000431	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DRB1—psoriasis	4.38e-05	0.000426	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ICAM1—psoriasis	4.21e-05	0.000409	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NFKBIA—psoriasis	4.17e-05	0.000406	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOE—psoriasis	4.14e-05	0.000402	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—psoriasis	4.03e-05	0.000392	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SOCS1—psoriasis	3.92e-05	0.000382	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS2—psoriasis	3.85e-05	0.000375	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NDUFA5—psoriasis	3.55e-05	0.000345	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TYK2—psoriasis	3.42e-05	0.000332	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.31e-05	0.000321	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—psoriasis	3.25e-05	0.000316	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNG—psoriasis	3.2e-05	0.000311	CbGpPWpGaD
Niclosamide—STAT3—Disease—TYK2—psoriasis	3.16e-05	0.000307	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD4—psoriasis	3.09e-05	0.000301	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NDUFA5—psoriasis	3.03e-05	0.000295	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP2S1—psoriasis	3.02e-05	0.000293	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOE—psoriasis	2.9e-05	0.000282	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LEP—psoriasis	2.9e-05	0.000282	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD4—psoriasis	2.85e-05	0.000278	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.83e-05	0.000275	CbGpPWpGaD
Niclosamide—STAT3—Immune System—JUN—psoriasis	2.77e-05	0.000269	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NFKBIA—psoriasis	2.7e-05	0.000262	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NFKB1—psoriasis	2.66e-05	0.000259	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP2S1—psoriasis	2.58e-05	0.00025	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TYK2—psoriasis	2.21e-05	0.000215	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—psoriasis	1.92e-05	0.000187	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—JUN—psoriasis	1.79e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NFKB1—psoriasis	1.72e-05	0.000167	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—psoriasis	1.67e-05	0.000163	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.58e-05	0.000154	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—psoriasis	1.56e-05	0.000152	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—psoriasis	1.54e-05	0.00015	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CARM1—psoriasis	1.47e-05	0.000143	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.38e-05	0.000134	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.35e-05	0.000131	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CARM1—psoriasis	1.26e-05	0.000122	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—psoriasis	1.18e-05	0.000115	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—psoriasis	1.08e-05	0.000105	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAT—psoriasis	9.06e-06	8.8e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAT—psoriasis	7.74e-06	7.52e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOE—psoriasis	7.04e-06	6.84e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—psoriasis	6.13e-06	5.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOE—psoriasis	6.01e-06	5.85e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—psoriasis	5.24e-06	5.09e-05	CbGpPWpGaD
